Emma A. Ghazaryan

Emma A. Ghazaryan

Auto-generated profile, based on publicly available information

Emma A. Ghazaryan

Department of Pesticides Synthesis and Expertise National Agrarian University of Armenia, Teryan 74, Yerevan, 0009, Armenia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
VPVergush A. Pivazyan
Vergush A. Pivazyan
EGEmma A. Ghazaryan
Emma A. Ghazaryan
RSRoza Shainova
Roza Shainova
RTRafael A. Tamazyan
Rafael A. Tamazyan
AAArmen G. Ayvazyan
Armen G. Ayvazyan
AYAleksandr P. Yengoyan
Aleksandr P. Yengoyan
A convenient, accessible, and high yield method for preparing of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (1) by treatment of acetoacetic acid ethyl ester with thiourea in sodium methylate was developed. The alkylation of the latter with 3-chloro-pentane-2,4-dione and further regioselective cyclization of intermediate compound (2) in high yield afforded 2-acetyl-3,7-dimethyl-5H-thiazolo[3,2-a]pyrimidin-5-one (3). The halogenation and some transformations of synthesized thiazolo[3,2-a]pyrimidine (3) due to its ketone group were carried out to obtain the corresponding carboxamide, carbothioamide, sulfonohydrazide, and oxime and its alkylated derivatives (5). At preliminary biological studies the synthesized compounds have shown growth stimulant properties. The activity of four of them was higher than 70%, compared with heteroauxin.

5 August 2013 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
KEKarine A. Eliazyan
Karine A. Eliazyan
AKAram M. Knyazyan
Aram M. Knyazyan
VPVergush A. Pivazyan
Vergush A. Pivazyan
EGEmma A. Ghazaryan
Emma A. Ghazaryan
SHSiranush V. Harutyunyan
Siranush V. Harutyunyan
AYAleksandr P. Yengoyan
Aleksandr P. Yengoyan

1 November 2022 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
TGT. A. Gomktsyan
T. A. Gomktsyan
RSR. S. Shainova
R. S. Shainova
AKArmen Karapetyan
Armen Karapetyan
EGE. A. Ghazaryan
E. A. Ghazaryan
SHS. V. Harutyunyan
S. V. Harutyunyan
VPV. A. Pivazyan
V. A. Pivazyan
Pyrazolylpyridazine is an interesting non-fused biheterocyclic system, which derivatives have a wide spectrum of biological activity. In this study, a targeted synthesis of a number of new potentially biologically active derivatives based on the corresponding 2-{[6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]thio}acetohydrazide was carried out. The synthesized compounds showed a pronounced stimulating effect on plant growth.

15 June 2024 in Veterinary World
Verified
Journal Article
Open access
AYAleksandr Yengoyan
Aleksandr Yengoyan
TGTiruhi Gomktsyan
Tiruhi Gomktsyan
VPVergush Pivazyan
Vergush Pivazyan
EGEmma Ghazaryan
Emma Ghazaryan
RSRoza Shainova
Roza Shainova
ZKZaven Alexandr Karalyan
Zaven Alexandr Karalyan
Background and Aim: With the emergence of severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), antiviral drug development has gained increased significance due to the high incidence and potentially severe complications of the resulting coronavirus infection. Heterocycle compounds, acting as antimetabolites of DNA and RNA monomers, rank among the most effective antiviral drugs. These compounds’ antiviral effects on various SARS-CoV-2 isolates, as found in existing data collections, form the basis for further research. The aim of this study was to examine the possible antiviral effect of some originally synthesized heterocyclic compounds. Materials and Methods: The main methods were cell culturing, cytotoxicity assay, qRT-PCR assay, tissue and blood cells analysis, and micro-computed tomography (micro-CT) imaging. Results: In both in vitro and in vivo conditions, the elimination of SARS-Cov-2 occurred significantly earlier after administration of the compounds compared to the control group. In hamsters, the primary symptoms of coronavirus disease disappeared following administration of heterocycle compounds. Conclusion: Using delta and omicron strains of the SARS-CoV-2 virus, newly created heterocycle compound analogs dramatically reduced SARS-CoV-2 multiplication, resulting in a drop in viral RNA load in the supernatant under in vitro conditions. Improvements in pathological manifestations in the blood, bone marrow, and internal organs of hamsters demonstrated that heterocycle compounds inhibited SARS-CoV-2 replication both in vitro and in vivo. Keywords: broad-spectrum antiviral agents, heterocycle compounds, in vitro, in vivo, severe acute respiratory syndrome-related coronavirus, Syrian hamsters.